- Home
- DXCM vs GEHC Comparison
DXCM vs GEHC Comparison
Compare DXCM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXCM | GEHC |
|---|---|---|
| Founded | 1999 | 1892 |
| Country | United States | United States |
| Employees | 11100 | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9B | 27.9B |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DXCM | GEHC |
|---|---|---|
| Price | $89.49 | $73.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | $85.33 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 5.3M | 4.9M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 47.18 | 4.84 |
| EPS | ★ 1.15 | 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $14.46 | $7.12 |
| Revenue Next Year | $12.31 | $4.45 |
| P/E Ratio | ★ $79.57 | $86.82 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $54.11 | $58.75 |
| 52 Week High | $91.62 | $89.77 |
Technical Indicators
Market Signals| Indicator | DXCM | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.69 | 68.54 |
| Support Level | $62.65 | $69.17 |
| Resistance Level | N/A | $75.95 |
| Average True Range (ATR) | 2.74 | 1.94 |
| MACD | 0.94 | 0.56 |
| Stochastic Oscillator | 88.64 | 99.25 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).